Concepedia

Jeremy Karlin

JK

7

Publications

464

Citations

7

H-Index

2012

Active since

Affiliations

Virginia Commonwealth University(Current)

Hunter Holmes McGuire VA Medical Center

Duke Medical Center

AstraZeneca (United Kingdom)

United States Department of Veterans Affairs

Jeremy Karlin is an author at Virginia Commonwealth University specializing in radiation therapy, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2012–2018

7

Publications

7

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models

Stephen T. Durant, Li Zheng, Yingchun Wang et al. · Science Advances · 2018 · 292 citations · Full text

Orally Bioavailable and Blood–Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice

Jeremy Karlin, Jasmine Allen, Syed Farhan Ahmad et al. · Molecular Cancer Therapeutics · 2018 · 61 citations · Full text

Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy

Drew Moghanaki, Bridget F. Koontz, Jeremy Karlin et al. · Cancer · 2012 · 52 citations · Full text

Comparative study of late rectal toxicity in prostate cancer patients treated with low-dose-rate brachytherapy: With or without supplemental external beam radiotherapy

Nicholas A. Serrano, Drew Moghanaki, David Asher et al. · Brachytherapy · 2016 · 21 citations

, , +7

Identifying Appropriate Patients for Early Salvage Radiotherapy after Prostatectomy

Jeremy Karlin, Bridget F. Koontz, Stephen J. Freedland et al. · The Journal of Urology · 2013 · 17 citations

Rows per page

1–5 of 7